These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31698824)

  • 21. Rotavirus vaccine administered parenterally induces protective immunity.
    Conner ME; Crawford SE; Barone C; Estes MK
    J Virol; 1993 Nov; 67(11):6633-41. PubMed ID: 8411366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity and immunogenicity of attenuated porcine epidemic diarrhea virus PC22A strain in conventional weaned pigs.
    Lin CM; Ghimire S; Hou Y; Boley P; Langel SN; Vlasova AN; Saif LJ; Wang Q
    BMC Vet Res; 2019 Jan; 15(1):26. PubMed ID: 30634958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model.
    Miyazaki A; Kandasamy S; Michael H; Langel SN; Paim FC; Chepngeno J; Alhamo MA; Fischer DD; Huang HC; Srivastava V; Kathayat D; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    Vaccine; 2018 Oct; 36(42):6270-6281. PubMed ID: 30219368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate.
    Xue M; Yu L; Che Y; Lin H; Zeng Y; Fang M; Li T; Ge S; Xia N
    Vaccine; 2015 May; 33(22):2606-13. PubMed ID: 25882173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.
    Fellows T; Page N; Fix A; Flores J; Cryz S; McNeal M; Iturriza-Gomara M; Groome MJ
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual functions of Lactobacillus acidophilus NCFM as protection against rotavirus diarrhea.
    Liu F; Wen K; Li G; Yang X; Kocher J; Bui T; Jones D; Pelzer K; Clark-Deener S; Yuan L
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):169-76. PubMed ID: 24126832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.
    Tô TL; Ward LA; Yuan L; Saif LJ
    J Gen Virol; 1998 Nov; 79 ( Pt 11)():2661-72. PubMed ID: 9820141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
    Yuan L; Azevedo MS; Gonzalez AM; Jeong KI; Van Nguyen T; Lewis P; Iosef C; Herrmann JE; Saif LJ
    Vaccine; 2005 Jun; 23(30):3925-36. PubMed ID: 15917114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies.
    Parre O V; Hodgins DC; de Arriba L; Kang SY; Yuan L; Ward LA; T TL; Saif LJ
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1417-1428. PubMed ID: 10374959
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Gilfillan D; Vilander AC; Pan M; Goh YJ; O'Flaherty S; Feng N; Fox BE; Lang C; Greenberg HB; Abdo Z; Barrangou R; Dean GA
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
    Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a bivalent recombinant vaccine candidate targeting norovirus and rotavirus: Antibodies to rotavirus NSP4 exert antidiarrheal effects without virus neutralization.
    Cao H; Wu J; Luan N; Wang Y; Lin K; Liu C
    J Med Virol; 2022 Aug; 94(8):3847-3856. PubMed ID: 35474320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response.
    Xia M; Huang P; Tan M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development.
    Velasquez DE; Jiang B
    Hum Vaccin Immunother; 2019; 15(12):3003-3008. PubMed ID: 31124743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes.
    Iosef C; Van Nguyen T; Jeong Ki; Bengtsson K; Morein B; Kim Y; Chang KO; Azevedo MS; Yuan L; Nielsen P; Saif LJ
    Vaccine; 2002 Mar; 20(13-14):1741-53. PubMed ID: 11906761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine.
    Lakatos K; McAdams D; White JA; Chen D
    Hum Vaccin Immunother; 2020 Aug; 16(8):1957-1968. PubMed ID: 31995444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.
    Roier S; Mangala Prasad V; McNeal MM; Lee KK; Petsch B; Rauch S
    NPJ Vaccines; 2023 Dec; 8(1):190. PubMed ID: 38129390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines.
    Nyblade C; Hensley C; Parreño V; Zhou P; Frazier M; Frazier A; Ramesh A; Lei S; Degiuseppe JI; Tan M; Yuan L
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560807
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Michael H; Miyazaki A; Langel SN; Amimo JO; Kick MK; Chepngeno J; Paim FC; Fischer DD; Rajashekara G; Saif LJ; Vlasova AN
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.